Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
MMM US CFR 21 Part 11 PAES Referral system DFI Network Source Data Verification Scientific advice Clinical trials Oncological patients Data Validation Plan Statistical services Dry powder inhaler Clinical study Hormone replacement therapy Ophthalmologist Degeneration Ophthalmological trials AGAH ADAM Authorities Consultancy Feasibility Statistical Analysis Plan DUS Absorption windows Ocular tolerability IEC GCP Ovulation inhibition Rhine Main area Highly variable drugs Intensive assessment station Eye disease Hypothalamic IB Lung Post authorisation Protocol HTA DDI CRA Legal representative Patch Oncologic network Postmenopausal women Uveitis Pharmacodynamic studies Contraception Data Management Plan Sample size estimation Transdermal therapeutic system Quality Management System CDM Database CRO Standardisation CRF Safety Oncology Efficacy HRT Clinical development program In vitro in vivo correlation Non interventional Phase IIb trials Life cycle management Sensitisation trials Pharmacology Sore throat Early phase Biopharmaceutics Pharmacokinetics FDA DPI Charcoal Subcontractor qualification Quality EMA Statistical programming Standard operating procedure CDISC Macular Slit lamp microscopy Phase III Phase II FIM Anaesthesiologist Protocol development Project Management Elpro Thuringia Sequential designs Patients GCP training Biopharmaceutical Pilot study Drug Food Interaction Pharmacokintetics MDI Scientific expertise Inhalatives Dose linearity Steady state CDASH GLP Paediatricians Axis Adrenocortical Edema Pragmatism Quality Assurance Asthma Patient recruitment Recruitment rates Bioavailability IVIVC Biosimilars SDV Absorption Endpoint Informed Consent Procedure SOP based Ophthalmology Clinical pharmacology unit Children Audit TTS NIS CDSIC ANVISA US FDA Investigators brochure MCID Clinical Monitoring SAS Inspection Phase I Unit Local tolerability Common cold Expert Competence Experience Phase IIa trials Creativity Centralised procedure Monitoring PASS Pulse oximetry plethysmography IMPD Healthy subjects ICF Gynaecological trials Copyright Phase IV Cardiovascular surveillance Training Pituitary Auditing Product development Female adolescents Data management OTC Metered dose inhaler Bioequivalence Cough Dry eye Glaucoma Spacious archive HPA axis Phase I Immunogenicity Xerostomia Dermal irritation COPD Good Clinical Practice Legal Information Central surveillance system Drug Drug Interaction Allergy Biometrics Design development Patch adhesion First in human SocraTec C&S WinNonlin  

All fine on front page